Sojourn (Piramal Critical Care Inc)


Welcome to the PulseAid listing for the Sojourn drug offered from Piramal Critical Care Inc. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Piramal Critical Care Inc
NON-PROPRIETARY NAME: Sevoflurane
SUBSTANCE NAME: SEVOFLURANE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: General Anesthesia [PE],General Anesthetic [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-04-13
END MARKETING DATE: 0000-00-00


Sojourn HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSojourn from Piramal Critical Care Inc
LABELER NAME: Piramal Critical Care Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mL/mL)
START MARKETING DATE: 2010-04-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66794-012_ea73f512-1c65-49bb-9925-c2d81931400c
PRODUCT NDC: 66794-012
APPLICATION NUMBER: ANDA077867

Other SEVOFLURANE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Ultane
Baxter Healthcare CorporationSevoflurane
Piramal Critical Care IncSojourn
Piramal Critical Care, Inc.Sevoflurane
Sandoz Inc.Sevoflurane